Shire Biotech India Private Limited, a amalgamated foreign private limited company, was established on 22 September 2017 in Gurgaon, Haryana, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U51909HR2017FTC070872. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Anoop Kishore Kamat (Director), Rajesh Eric Dmellokamath (Director), Gopal Agrawal (Director). Past directors included Aparna Jetly, Vineet Singhal, Anoop Kishore Kamat. Its latest AGM occurred on 20 September 2022, with the balance sheet filed on 31 March 2022. It is based at 6Th Floor, Tower C, Building No. 8, Dlf Cyber City, Dlf Phase Ii,, Gurgaon, Haryana, 122001.
U51909HR2017FTC070872
070872
22 September 2017
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Amalgamated
Explore comprehensive insights into Shire Biotech India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anoop Kishore Kamat | Director | 23 Apr 2021 | Current |
| Rajesh Eric Dmellokamath | Director | 31 Jul 2021 | Current |
| Gopal Agrawal | Director | 08 Aug 2019 | Current |
| Serina Magner Fischer | Director | 16 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Aug 2019 | Past |
| Pramod Abcsdd | Director | 15 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 01 Jul 2021 | Past |
| Pramod Abcsdd | Director | 31 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shire Biotech India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.41% increase. The company also saw a slight improvement in profitability, with a 4.94% increase in profit. The company's net worth Soared by an impressive increase of 84.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Shire Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shire Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shire Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shire Biotech India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shire Biotech India Private Limited last Annual general meeting of members was held on 20 Sep 2022 as per latest MCA records. was completed.
Progress on Shire Biotech India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was documented.
Progress on Serina Magner Fischer was appointed as a Director was appointed as a Director on 16 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
Rajesh Eric Dmellokamath was appointed as a Director was appointed as a Director on 31 Jul 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
Progress on Anoop Kishore Kamat was appointed as a Director was appointed as a Director on 23 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
The activity Gopal Agrawal was appointed as a Director was appointed as a Director on 08 Aug 2019 & has been associated with this company since 6 years 3 months . was completed.
Curadev: We got a new STING thing! Licensed our small molecule to boost interferon genes. #ScienceGoals #Innovation #STINGagonist.
The CIN of Shire Biotech India Private Limited is U51909HR2017FTC070872.
Shire Biotech India Private Limited is headquartered at 6Th Floor, Tower C, Building No. 8, Dlf Cyber City, Dlf Phase Ii,, Gurgaon, Haryana, 122001.
Shire Biotech India Private Limited was incorporated on 22 September 2017.
The current directors of Shire Biotech India Private Limited are
The primary industry of Shire Biotech India Private Limited is Life Sciences.
Shire Biotech India Private Limited is unlisted.
The authorized capital of Shire Biotech India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Shire Biotech India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX